hrs4r
Quiero donar

RENÉ ROBERTO ROBLES CEDEÑO

Firma
RENÉ ROBERTO ROBLES-CEDEÑO
Posición
Investigador/a Consolidat - R3
Investigador/a Consolidado - R3

Projectes

Codi oficial: RD21/0002/0063 - EM Data inicio:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 136,744.30 €
Codi oficial: Estudio de biomarcadores moleculares neurodegeneración Data inicio:01/01/2022 Data fi: 31/12/2023 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: FRANCISCO SORIA MELGUIZO, S.A Ajuda: 325,600 €

Publicacions

Zabalza A, Arrambide G, Otero-Romero S, Pappolla A, Tagliani P, López-Maza S, Cárdenas-Robledo S, Esperalba J, Fernández-Naval C, Martínez-Gallo M, Castillo M, Bonastre M, Resina-Salles M, Bertran J, Rodriguez-Barranco M, Carbonell-Mirabent P, Gonzalez M, Merchan M, Quiroga-Varela A, Miguela A, Gómez I, Álvarez G, Robles R, Perez Del Campo D, Queralt X, Soler MJ, Agraz I, Martinez-Valle F, Rodríguez-Acevedo B, Midaglia L, Vidal-Jordana Á, Cobo-Calvo Á, Tur C, Galan I, Castillo J, Río J, Espejo C, Comabella M, Nos C, Sastre-Garriga J, Ramió-Torrentà L, Tintoré M, Montalban X

Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

MULTIPLE SCLEROSIS JOURNAL, 2022, 28, 1138-1145 dx.doi.org/10.1177/13524585221089540
0

Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives

Cells, 2022, 11 dx.doi.org/10.3390/cells11132058

Muñoz-San Martín M, Gomez I, Miguela A, Belchí O, Robles-Cedeño R, Quintana E, Ramió-Torrentà L

Description of a CSF-Enriched miRNA Panel for the Study of Neurological Diseases.

LIFE-BASEL, 2021, 11 dx.doi.org/10.3390/life11070594

Coll-Martinez C, Quintana E, Salavedra-Pont J, Buxó M, González-Del-Rio M, Gómez I, Muñoz-San Martín M, Villar LM, Álvarez-Bravo G, Robles-Cedeño R, Ramió-Torrentà L, Gich J

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

BRAIN AND BEHAVIOR, 2021, 11 dx.doi.org/10.1002/brb3.2405

Ziemssen T, Giovannoni G, Alvarez E, Bhan V, Hersh C, Hoffmann O, Oreja-Guevara C, Robles-Cedeño RR, Trojano M, Vermersch P, Dobay P, Khwaja M, Stadler B, Rauser B, Hach T, Piani-Meier D, Burton J

Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey.

JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 dx.doi.org/10.2196/29558

Rigau PV, Moral S, Bosch D, Morales M, Frigola JM, Albert X, Robles R, Ballesteros E, Roqué M, Aboal J, Brugada R

Clinical Prognosis of Right-Sided Infective Endocarditis not Associated with Cardiac Devices or Intravenous Drug use: a Cohort Study and Meta-Analysis.

SCIENTIFIC REPORTS, 2020, 10, 7179-7179 dx.doi.org/10.1038/s41598-020-64220-z

Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L

Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.

JOURNAL OF NEUROINFLAMMATION, 2019, 16, 220-220 dx.doi.org/10.1186/s12974-019-1590-5

Quintana E, Coll C, Salavedra-Pont J, Muñoz-San Martín M, Robles-Cedeño R, Tomàs-Roig J, Buxó M, Matute-Blanch C, Villar LM, Montalban X, Comabella M, Perkal H, Gich J, Ramió-Torrentà L

Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.

EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25, 1189-1191 dx.doi.org/10.1111/ene.13687

Gil-Varea E, Urcelay E, Vilariño-Güell C, Costa C, Midaglia L, Matesanz F, Rodríguez-Antigüedad A, Oksenberg J, Espino-Paisan L, Dessa Sadovnick A, Saiz A, Villar LM, García-Merino JA, Ramió-Torrentà L, Triviño JC, Quintana E, Robles R, Sánchez-López A, Arroyo R, Alvarez-Cermeño JC, Vidal-Jordana A, Malhotra S, Fissolo N, Montalban X, Comabella M

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

JOURNAL OF NEUROINFLAMMATION, 2018, 15, 265-265 dx.doi.org/10.1186/s12974-018-1307-1

Robles-Cedeno R, Ramio-Torrenta L

Cladribina en el tratamiento de la esclerosis multiple recurrente.

REVISTA DE NEUROLOGIA, 2018, 67, 343-354 dx.doi.org/10.33588/rn.6709.2018184

Formulari de contacte

Conoce el IDIBGI!

menu